Product NDC: | 55154-8295 |
Proprietary Name: | Acyclovir |
Non Proprietary Name: | Acyclovir |
Active Ingredient(s): | 200 mg/1 & nbsp; Acyclovir |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-8295 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074556 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970423 |
Package NDC: | 55154-8295-0 |
Package Description: | 10 BLISTER PACK in 1 BAG (55154-8295-0) > 1 TABLET in 1 BLISTER PACK |
NDC Code | 55154-8295-0 |
Proprietary Name | Acyclovir |
Package Description | 10 BLISTER PACK in 1 BAG (55154-8295-0) > 1 TABLET in 1 BLISTER PACK |
Product NDC | 55154-8295 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acyclovir |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970423 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | ACYCLOVIR |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |